Liguori, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 692
EU - Europa 643
AS - Asia 194
AF - Africa 7
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.541
Nazione #
US - Stati Uniti d'America 690
SE - Svezia 184
IT - Italia 167
IE - Irlanda 85
SG - Singapore 73
ID - Indonesia 50
DE - Germania 43
CN - Cina 31
FI - Finlandia 27
RU - Federazione Russa 27
BE - Belgio 23
FR - Francia 19
GB - Regno Unito 19
IN - India 17
CZ - Repubblica Ceca 12
CH - Svizzera 8
HK - Hong Kong 8
UA - Ucraina 8
CI - Costa d'Avorio 7
IR - Iran 6
RO - Romania 5
TR - Turchia 5
AT - Austria 4
PL - Polonia 4
BR - Brasile 2
CA - Canada 2
CL - Cile 2
NL - Olanda 2
VN - Vietnam 2
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
JP - Giappone 1
NO - Norvegia 1
PH - Filippine 1
RS - Serbia 1
Totale 1.541
Città #
Chandler 141
Dublin 85
Ashburn 79
New York 54
Singapore 52
Jakarta 50
Chicago 46
Rome 39
Milan 29
Helsinki 25
Moscow 24
Brussels 23
Castelnuovo di Val di Cecina 17
Los Angeles 17
Princeton 15
San Mateo 15
Boston 13
Beijing 12
Brno 12
Marseille 11
Wilmington 10
Bremen 9
Falls Church 9
Hong Kong 8
Munich 8
Palermo 8
Abidjan 7
Norwalk 7
Zurich 7
Augusta 6
Woodbridge 6
Boardman 5
Fairfield 5
Seattle 5
Genoa 4
Kish 4
Portland 4
Warsaw 4
Washington 4
Atlanta 3
Cattolica 3
Houston 3
Lanciano 3
Pune 3
Treviso 3
Viterbo 3
Abbiategrasso 2
Andover 2
Buftea 2
Busto Arsizio 2
Capannori 2
Cincinnati 2
Cluj-Napoca 2
Edinburgh 2
Falkenstein 2
Fontanelle 2
Fort Worth 2
Frankfurt am Main 2
Graz 2
Guangzhou 2
Hangzhou 2
Havant 2
Hounslow 2
Izmir 2
Lappeenranta 2
London 2
Meppel 2
Montreal 2
Nuremberg 2
Perugia 2
Philadelphia 2
Pollena Trocchia 2
Priverno 2
Provo 2
Redwood City 2
Rio de Janeiro 2
Santiago 2
Alexandria 1
Ann Arbor 1
Bari 1
Bern 1
Boisar 1
Budapest 1
Buffalo 1
Chiswick 1
Comiso 1
Dallas 1
Dearborn 1
Dong Ket 1
Egham 1
Fayetteville 1
Gurgaon 1
Hanoi 1
Hebei 1
Jacksonville 1
Mainz 1
Manchester 1
Manila 1
Mercato San Severino 1
Miami 1
Totale 985
Nome #
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 85
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 83
Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life 74
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 72
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 70
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 65
Acute HEV hepatitis: clinical and laboratory diagnosis 57
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 54
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 52
The role of elastography in non-Alcoholic fatty liver disease 51
Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs 45
Gallbladder perforation without cholecystitis in a patient awaiting liver transplantation: a peculiar case report of anaemia in cirrhosis 42
Reasons for Tooth Extractions and Related Risk Factors in Adult Patients: A Cohort Study 41
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: Time for reappraisal of BMI-driven approach? 39
Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD) 38
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 37
URINARY LITHOGENIC PROFILE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 35
URINARY LITHOGENIC PROFILE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 34
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 30
Nonalcoholic fatty liver disease (Nafld) as model of gut–liver axis interaction: From pathophysiology to potential target of treatment for personalized therapy 30
Urinary lithogenic profile of patients with non-alcoholic fatty liver disease 29
Use of imaging techniques for non-invasive assessment in the diagnosis and staging of non-alcoholic fatty liver disease 29
Longitudinal prognostic value of the most common algorithms for fibrosis in non-alcoholic fatty liver disease. An international study in non-cirrhotic, biopsy-proven patients 27
FREQUENCY AND REASONS FOR NON-LISTING IN REFERRED ADULT PATIENTS FOR LIVER TRANSPLANTATION 27
Longitudinal prognostic value of the most common algorithms for fibrosis in non-alcoholic fatty liver disease: An international study in non-cirrhotic, biopsy-proven patients 26
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease 26
General Practitioner databaSe NAFLD (GPS-NAFLD) Study: preva-lence of advanced liver fibrosis among Italian primary care pa-tients with NAFLD 25
Clinical Characteristics and Long-Term Outcomes of Lean Caucasian Patients with Non-Alcoholic Fatty Liver Disease. a Longitudinal International Study 25
Clinical impact of comorbidities in an Italian NAFLD cohort 22
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores 22
Correlation of the transaminases alteration with the clinical severity of patients with COVID-19: A meta-analysis of the first global outbreak 21
Non-alcoholic fatty liver disease and the risk of fibrosis in Italian primary care services: GPS-NAFLD Study 21
Liver stiffness in the early post-liver transplant phase as a marker of acute allograft rejection 21
COMMON CLINICAL COMORBIDITIES IN AN ITALIAN NAFLD COHORT 21
HEPATOMA ARTERIAL-EMBOLISATION PROGNOSTIC SCORE PREDICTS PROGRESSION IN HEPATOCELLULAR CARCINOMA TREATED BY RADIOFREQUENCY ABLATION PLUS TRANSARTERIAL CHEMOEMBOLIZATION 20
FREQUENCY OF AND REASONS BEHIND NON-LISTING IN ADULT PATIENTS REFERRED FOR LIVER TRANSPLANTATION 19
Steatohepatitis and type 2 diabetes mellitus are influenced by genetic susceptibility to increased intestinal permeability in patients with non-alcoholic fatty liver disease 19
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study 19
Letter to the Editor: Suboptimal performance of CAR-OLT score to predict 1-year risk of cardiovascular events after liver transplantation 18
Increased serum ferritin levels predict long-term mortality in patients with NAFLD 17
Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors 17
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 17
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease 16
Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties 15
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease 14
TACROLIMUS BLOOD-BILE RATIO FOR THE EARLY DETECTION OF THE REJECTION GRAFT INJURY AFTER LIVER TRANSPLANTATION 13
Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues 13
Clinical Characteristics and Long-Term Outcomes of Lean Caucasian Patients with Non-Alcoholic Fatty Liver Disease. a Longitudinal International Study 7
Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves 5
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women 4
Totale 1.609
Categoria #
all - tutte 11.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.407


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202029 0 0 13 0 2 0 2 0 3 0 9 0
2020/202184 2 0 4 18 2 1 6 11 5 9 23 3
2021/2022159 7 3 5 20 16 9 4 28 8 4 28 27
2022/2023643 58 50 24 54 80 96 57 49 56 40 56 23
2023/2024582 46 149 26 38 28 83 51 17 8 40 28 68
2024/2025104 20 5 79 0 0 0 0 0 0 0 0 0
Totale 1.609